CD8A and infection: So far, few works have studied the differences in breadth and magnitude of CD8+ T-cell responses arising from starting cART at different time-points after infection (54, 62, 63), but no evaluation has been focused on how those differences impact on the final antiviral activity, an important issue to be addressed when assessing functional cure strategies.